You are using an outdated browser. Please upgrade your browser to improve your experience and security.

Skip to content
Loading...

Home

Today’s evolving HSCT landscape requires… READINESS. RECOGNITION. REACTION.

Increased vigilance is key to identifying veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS)

Explore current diagnostic criteria

Checkmark icon

Risk factors for VOD/SOS

Know risk factors that can lead to VOD/SOS, a potentially life-threatening and rapidly progressing complication1-3

Risk factors

Liver icon

Signs and symptoms of VOD/SOS progression

Be ready to act by knowing the signs and symptoms of rapidly progressing VOD/SOS1,4,5

Signs and symptoms

Play icon

An in-depth look at the complex pathogenesis of VOD/SOS

Take a closer look at the processes involved in the development of VOD/SOS

Watch video

HSCT=hematopoietic stem-cell transplantation; SOS=sinusoidal obstruction syndrome; VOD=veno-occlusive disease.

References: 1. Coppell JA, Richardson PG, Soiffer R, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16(2):157-168. 2. Carreras E, Díaz-Beyá M, Rosiñol L, et al. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant. 2011;17(11):1713-1720. 3. Richardson PG, Ho VT, Cutler C, et al. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions. Biol Blood Marrow Transplant. 2013;19 (suppl 1):S88-S90. 4. McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993;118(4):255-267. 5. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood. 1995;85(11):3005-3020.